Protein Degradation Overview

Principles

Definition

Protein degradation is the fundamental biological process involving the breakdown of proteins into smaller peptides or amino acids within living organisms. As a critical area of research, it encompasses the study of the diverse molecular mechanisms, regulatory networks, and essential cellular functions mediated by this process, including protein turnover, quality control, and signal modulation.

Ontological type

Molecular Pathways

Regulatory Mechanisms

Cellular Functions

Key developments

Key Figures

Foundations of Proteolysis era

Moshe Oren [1] conducted research at Rockefeller University [2] and the Weizmann Institute of Science [3] during the Foundations of Proteolysis era (1964-2000). His key contribution in this era centers on the paper Mdm2 promotes the rapid degradation of p53 [4], which demonstrated how this interaction drives rapid turnover of a pivotal regulatory protein. This work helped frame proteolysis as a regulated process with direct implications for cellular signaling and homeostasis in the era's mechanistic investigations. Through these findings, Oren's research contributed to establishing proteolysis as a central component of the cellular regulatory network that the era's foundational studies sought to map.

Selective Autophagy and Ubiquitin era

Terje Johansen [1] is associated with Goethe University Frankfurt [4] and Washtenaw Community College [3] during the selective autophagy era. His key contribution is reflected in the 2007 paper on p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy [6], establishing p62 as a cargo receptor that links ubiquitinated substrates to the autophagy machinery and driving selective clearance in this era. Andreas Brech [2] is associated with University of Oslo [5] during this era. Brech [2]'s contributions include co-authoring the 2007 paper that demonstrates how p62/SQSTM1 bridges ubiquitinated cargo to Atg8/LC3 and autophagy, a finding that underpins selective clearance and quality-control programs in this era [6].

Engineered Targeted Degradation era

Nathanael S. Gray[1] is a leading figure in the Engineered Targeted Degradation era, with affiliations at Harvard University[2] and the Massachusetts Institute of Technology[3]. His 2018 work introducing the dTAG system for immediate and target-specific protein degradation[4] describes a modular approach that recruits the ubiquitin–proteasome pathway to rapidly remove chosen proteins, a breakthrough that enabled rapid functional studies and accelerated therapeutic exploration in this field. Nathanael S. Gray[1] is again associated with Harvard University[2] and the Massachusetts Institute of Technology[3], reinforcing the cross-institutional base driving this era's exploration of degrader technologies. Gray[1]'s contributions, anchored by the dTAG framework described in the 2018 paper[4], underscored the importance of binding geometry and temporal kinetics in target selectivity and helped steer the era toward broader deployment of degraders across challenging proteins and into receptor-mediated strategies[4].